Vergoeding 2017-2021 voor ATC-subgroep N03A : Anti-epileptica
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| N03AA Barbituraten en verwante verbindingen | 1.475.200 | 1.503.800 | 1.478.000 | 1.793.300 | 1.796.000 |
| N03AB Hydantoinederivaten | 162.100 | 164.310 | 148.660 | 179.700 | 169.250 |
| N03AD Succinimidederivaten | 111.630 | 113.180 | 116.610 | 123.420 | 211.210 |
| N03AE Benzodiazepinederivaten | 559.870 | 531.380 | 521.280 | 497.980 | 465.680 |
| N03AF Carboxamidederivaten | 4.056.800 | 3.866.100 | 3.964.700 | 4.047.100 | 4.068.900 |
| N03AG Vetzuurderivaten | 7.247.400 | 6.938.800 | 7.362.600 | 7.855.400 | 7.417.900 |
| N03AX Overige anti-epileptica | 38.912.400 | 26.618.600 | 27.742.300 | 31.655.000 | 31.665.400 |
| Totaal | 52.525.400 | 39.736.170 | 41.334.150 | 46.151.900 | 45.794.340 |